38 studies found for:    " August 25, 2010":" September 24, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: YASMIN;   Drug: GSK2248761;   Other: Placebo
22 Recruiting ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
23 Completed GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1349572;   Drug: Fosamprenavir;   Drug: Ritonavir
24 Unknown  Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients
Condition: HIV
Intervention: Drug: raltegravir
25 Unknown  Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
Condition: AIDS
Intervention: Drug: INH RIF Rifb  PZA EMB AZT 3TC D4T EFV
26 Completed
Has Results
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Conditions: HIV;   Cancer
Interventions: Biological: Fluzone High Dose Vaccine;   Biological: Fluzone Standard Dose Vaccine
27 Unknown  Study of Recently HIV Infected Men and Transmission Behaviors
Condition: HIV
Intervention:
28 Recruiting Cohort of Young Adults Infected With HIV Since Birth or During Childhood
Conditions: HIV Infection;   Young Adult
Intervention: Biological: blood sampling, specific biological exams and biobank and self administered questionnaires
29 Completed
Has Results
Atripla to Raltegravir Switch Study for CNS Toxicity
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
30 Recruiting Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Conditions: Adult Grade III Lymphomatoid Granulomatosis;   AIDS-Related Diffuse Large Cell Lymphoma;   HIV Infection;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Immunoblastic Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Adult Diffuse Mixed Cell Lymphoma;   Stage I Adult Immunoblastic Lymphoma;   Stage I Adult Lymphoblastic Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage II Adult Contiguous Immunoblastic Lymphoma;   Stage II Adult Non-Contiguous Immunoblastic Lymphoma;   Stage II Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma;   Stage II Contiguous Adult Lymphoblastic Lymphoma;   Stage II Contiguous Mantle Cell Lymphoma;   Stage II Grade 3 Contiguous Follicular Lymphoma;   Stage II Grade 3 Non-Contiguous Follicular Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma;   Stage II Non-Contiguous Adult Lymphoblastic Lymphoma;   Stage II Non-Contiguous Mantle Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Immunoblastic Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Immunoblastic Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate;   Drug: Vorinostat
31 Completed PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
Condition: HIV Infection
Intervention: Drug: Maraviroc
32 Recruiting Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
Condition: HIV Infection and Chronic Alanine Aminotransferase Elevation
Intervention: Other: Fibroscan
33 Completed Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study
Conditions: Hiv Infection;   Lung Cancer
Intervention: Radiation: Low dose computed tomography (CT)
34 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Related
Intervention:
35 Completed
Has Results
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
Conditions: Genital Warts;   Human Papilloma Virus
Intervention: Procedure: Medical / Surgical Treatment
36 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
37 Completed Comparison of the Shang Ring With Conventional Surgical Methods
Condition: Circumcision, Male
Interventions: Device: Shang Ring;   Procedure: Male circumcision
38 Completed Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
Condition: Male Circumcision
Intervention: Device: Shang Ring

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Indicates status has not been verified in more than two years